Atlas Trials

Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer

Clinical trial NCT00489359 · COMPLETED

Trial details

NCT number
NCT00489359
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ovarian CancerPrimary Peritoneal Cancer
Start date
2005-07-01
Primary completion
2010-02-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.